Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
M. Paesmans (Brussels, Belgium). How can we validate a predictive factor and bring it into clinical practice?. Annual Congress 2011 - Prognostic and predictive factors in lung cancer

Member's Comments

No comment yet.

Related content which might interest you: Predictive factors: can we identify patients who will benefit from a specific treatment? Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer Year: 2011 What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008 Independent prognostic factors and prognostic classifications: how can we predict survival on the basis of clinical, pathological and routine biological factors? Source: Annual Congress 2011 - Prognostic and predictive factors in lung cancer Year: 2011 The challenge of providing proteomic tools in clinical practice Source: Annual Congress 2011 - PG3 Workshop: Genomics and proteomics of lung disease Year: 2011 Clinical relevance and implication for therapy Source: Annual Congress 2011 - Small airways: important in COPD and severe asthma Year: 2011 How pharmacokinetic/pharmacodynamic science informs dosage recommendations? Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice Year: 2010 Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014 State-of-the-art: development of evidence-based clinical practice guidelines Source: Annual Congress 2011 - PG13 ERS/ACCP jointly organised: evidence-based approach to advanced respiratory care Year: 2011 New technologies in bronchoscopy: which are still research tools and which are ready for clinical use? Source: Annual Congress 2010 - PG13 Core Curriculum Postgraduate Course: Interventional pulmonology Year: 2010 Are biomarkers helpful in sepsis for risk assessment or clinical trials? Source: Annual Congress 2011 - Molecular biomarkers at the bedside of critically ill patients Year: 2011 The NIVO score: can it help to improve noninvasive ventilation in daily clinical practice? Source: Eur Respir J, 58 (2) 2100336; 10.1183/13993003.00336-2021 Year: 2021 Why aren't guidelines being implemented in daily practice? Source: Annual Congress 2010 - PG20 Postgraduate Course: Implementing asthma guidelines for children in daily practice Year: 2010 What type of clinical evidence is needed to assess medical devices? Source: Eur Respir Rev 2016; 25: 259-265 Year: 2016 To treat or not to treat: an important question Source: Annual Congress 2011 - Slow-growing lung cancer Year: 2011 The added value of active patient involvement in health research Source: Annual Congress 2011 - The value of patients as partners in research Year: 2011 Assessment and treatment of comorbidity: what efforts pay off? Source: Annual Congress 2011 - The non-parmacological management of COPD exacerbations Year: 2011